A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01)
Patent
CA 2431415
The present invention is directed to a new process for granulating valproate compounds, such as divalproex sodium, in which the compound is melted in the absence of a binder and admixed with one or more excipients to produce granules. The resulting dosage forms have an increased drug loading factor in the range of 75 w/w% to 90 w/w%.
La présente invention concerne un nouveau procédé de granulation de composés de valproate, tels que le divalproex de sodium, dans lequel le composé est mélangé en l'absence de liant puis mélangé à nouveau avec un ou plusieurs excipients pour produire des granules. Les formes posologiques résultantes présentent un facteur de charge du médicament plus important qui se situe dans la fourchette comprise entre 75 % en poids et 90 % en poids.
Chermak Todd E.
Engh Kevin R.
Faitsch Lynn
Qiu Yihong
Slade Russell T.
Abbott Laboratories
Torys Llp
LandOfFree
Divalproex sodium dosage forms and a process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Divalproex sodium dosage forms and a process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Divalproex sodium dosage forms and a process for their... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1613285